Top articles of the week from Specialty Pharmacy Times.
New medical information website provides pharmacists and other providers with both in-label and potential off-label medication information.
No evidence found that erectile dysfunction drugs cause melanoma.
Indication for the treatment of adults and pediatric patients with solid tumors containing MSI-H or dMMR.
Sarilumab plus DMARDs demonstrated statistically significant improvements in patients with moderate to severe RA.
Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.